10 months ago
TEVA
AnalystsAshwani VermaAshwani Verma's Stock Forecasts
AnalystsAshwani Verma
Analyst Ranking
Bottom 12%
#4320 out of 4870 analysts
Average Return
-4.32%
Win Rate
33%17 out of 52
Risk vs Reward
Poor
Good
Ashwani Verma's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arcellx IncACLX | +164.51% | $35.16 | $93.00 | 2023-10-17 - 2024-10-16 | Strong Buy |
Cytokinetics IncCYTK | +116.84% | $37.71 | $81.77 | 2023-04-03 - 2024-01-24 | Strong Buy |
Teva Pharmaceutical Industries LtdTEVA | +67.91% | $9.88 | $16.59 | 2023-11-27 - 2024-11-26 | Strong Buy |
Neurocrine Biosciences IncNBIX | +53.52% | $96.03 | $147.43 | 2023-07-13 - 2024-07-12 | Strong Buy |
Neurocrine Biosciences IncNBIX | +37.07% | $100.38 | $137.59 | 2023-04-04 - 2024-04-03 | Strong Buy |
Ashwani Verma Analyst Color
Get additional color on Ashwani Verma's coverage of popular stocks
a year ago
LEGN
a year ago
ITCI
Ashwani Verma's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Harmony Biosciences Holdings IncHRMY | 2 | Strong Buy | $48.00 | +60.75% | Maintains | 4 days ago |
Acadia Pharmaceuticals IncACAD | 4 | Strong Buy | $22.00 | +51.00% | Maintains | 4 days ago |
Alkermes PLCALKS | 3 | Hold | $33.00 | +7.91% | Maintains | 4 days ago |
Coherus Biosciences IncCHRS | 5 | Hold | $1.05 | 0.00% | Maintains | 8 days ago |
Neurocrine Biosciences IncNBIX | 7 | Strong Buy | $137.00 | +28.53% | Maintains | a month ago |
Jazz Pharmaceuticals PLCJAZZ | 6 | Strong Buy | $179.00 | +52.76% | Upgrades | 2 months ago |
Teva Pharmaceutical Industries LtdTEVA | 8 | Strong Buy | $27.00 | +72.86% | Maintains | 3 months ago |
Exelixis IncEXEL | 2 | Hold | $34.00 | -12.57% | Maintains | 3 months ago |
Avadel Pharmaceuticals PLCAVDL | 2 | Strong Buy | $14.00 | +62.60% | Maintains | 4 months ago |
United Therapeutics CorpUTHR | 4 | Strong Buy | $475.00 | +61.65% | Maintains | 4 months ago |
Arcellx IncACLX | 2 | Strong Buy | $114.00 | +73.97% | Maintains | 5 months ago |
Biohaven LtdBHVN | 3 | Strong Buy | $54.00 | +140.53% | Maintains | 9 months ago |
Intra Cellular Therapies IncITCI | 5 | Hold | $79.00 | -40.09% | Maintains | 9 months ago |
Axsome Therapeutics IncAXSM | 2 | Strong Buy | $105.00 | -6.45% | Maintains | 9 months ago |
Royalty Pharma PLCRPRX | 3 | Hold | $28.00 | -13.79% | Downgrades | a year ago |
Legend Biotech CorpLEGN | 2 | Strong Buy | $81.00 | N/A | Maintains | a year ago |
Cytokinetics IncCYTK | 4 | Hold | $92.00 | N/A | Downgrades | a year ago |
Coherent CorpCOHR | 1 | Strong Buy | $7.00 | N/A | Maintains | 2 years ago |
Karuna Therapeutics IncKRTX | 2 | Hold | $209.00 | N/A | Initiates Coverage On | 2 years ago |
Viatris IncVTRS | 2 | Hold | $12.00 | N/A | Upgrades | 2 years ago |
Rani Therapeutics Holdings IncRANI | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 3 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 3 | Hold | $71.00 | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.